HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lapo Alinari Selected Research

milatuzumab

3/2012FTY720-induced blockage of autophagy enhances anticancer efficacy of milatuzumab in mantle cell lymphoma: is FTY720 the next autophagy-blocking agent in lymphoma treatment?
12/2011FTY720 increases CD74 expression and sensitizes mantle cell lymphoma cells to milatuzumab-mediated cell death.
4/2011Combination anti-CD74 (milatuzumab) and anti-CD20 (rituximab) monoclonal antibody therapy has in vitro and in vivo activity in mantle cell lymphoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Lapo Alinari Research Topics

Disease

21Neoplasms (Cancer)
07/2022 - 10/2005
20Lymphoma (Lymphomas)
01/2022 - 08/2002
12Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
01/2020 - 01/2009
10Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2022 - 08/2002
8Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
11/2021 - 03/2005
7Hodgkin Disease (Hodgkin's Disease)
04/2018 - 08/2002
6B-Cell Lymphoma (Lymphoma, B Cell)
11/2020 - 12/2002
3B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2021 - 11/2010
3Hematologic Neoplasms (Hematological Malignancy)
01/2021 - 04/2018
3Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
06/2011 - 07/2004
3Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous)
09/2007 - 09/2005
3Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
09/2007 - 05/2005
3Marginal Zone B-Cell Lymphoma (MALT Lymphoma)
10/2006 - 05/2003
2Genetic Translocation (Chromosomal Translocation)
12/2018 - 02/2012
2T-Cell Lymphoma (Lymphoma, T Cell)
04/2010 - 05/2005
2Pathologic Complete Response
06/2006 - 07/2004
2Mycosis Fungoides
12/2005 - 09/2005
1Disease Progression
04/2021
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2021
1Headache (Headaches)
04/2019
1Atrial Fibrillation
04/2019
1Infections
04/2019
1Hemorrhage
04/2019
1Graft vs Host Disease (Graft-Versus-Host Disease)
01/2017
1Epstein-Barr Virus Infections
09/2016
1Glioblastoma (Glioblastoma Multiforme)
03/2014
1Oral Ulcer (Mouth Ulcer)
12/2012
1Breast Neoplasms (Breast Cancer)
09/2012
1Leukemia
09/2012
1B-Cell Leukemia (Leukemia, B Cell)
09/2012
1Multiple Sclerosis
12/2011
1Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome)
06/2011
1T-Cell Leukemia (Leukemia, T Cell)
09/2009
1Sezary Syndrome (Sezary Erythroderma)
12/2005
1Anemia
10/2005

Drug/Important Bio-Agent (IBA)

9Rituximab (Mabthera)FDA Link
01/2022 - 09/2003
5Cyclin D1IBA
01/2020 - 06/2010
5Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
04/2009 - 10/2004
4Proteins (Proteins, Gene)FDA Link
11/2021 - 03/2005
4ibrutinibIBA
04/2021 - 04/2019
4Monoclonal AntibodiesIBA
04/2018 - 11/2010
4fludarabineIBA
12/2005 - 05/2004
3Agammaglobulinaemia Tyrosine KinaseIBA
04/2021 - 04/2019
3Protein-Arginine N-Methyltransferases (Methyltransferase, Protein Arginine)IBA
01/2021 - 03/2014
3Arginine (L-Arginine)FDA Link
01/2021 - 04/2015
3Fingolimod Hydrochloride (FTY720)FDA Link
03/2012 - 06/2010
3milatuzumabIBA
03/2012 - 04/2011
3Bortezomib (Velcade)FDA Link
06/2011 - 09/2007
3Epirubicin (Ellence)FDA LinkGeneric
11/2008 - 08/2002
3IfosfamideFDA LinkGeneric
11/2008 - 08/2002
3Etoposide (VP 16)FDA LinkGeneric
11/2008 - 08/2002
3Cyclophosphamide (Cytoxan)FDA LinkGeneric
12/2005 - 05/2004
2Pharmaceutical PreparationsIBA
04/2021 - 12/2011
2ChromatinIBA
01/2021 - 03/2014
2EnzymesIBA
01/2021 - 04/2015
2pembrolizumabIBA
04/2018 - 09/2016
2LigandsIBA
09/2016 - 09/2009
1Methotrexate (Mexate)FDA LinkGeneric
01/2022
1NVP-BKM120IBA
01/2022
1TransducinIBA
11/2021
1KPT-9274IBA
01/2021
1SNX-5422IBA
01/2021
1Histone Deacetylases (Histone Deacetylase)IBA
01/2021
1Nicotinamide PhosphoribosyltransferaseIBA
01/2021
1selinexorIBA
11/2020
1Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
01/2020
1zanubrutinibIBA
01/2020
1MicroRNAs (MicroRNA)IBA
01/2020
1Immune Checkpoint ProteinsIBA
10/2019
1acalabrutinibIBA
04/2019
1Phosphotransferases (Kinase)IBA
12/2018
1Oncogene Proteins (Oncogene Protein)IBA
12/2018
1PLX51107IBA
01/2018
1Immune Checkpoint InhibitorsIBA
01/2017
1NivolumabIBA
01/2017
1Histones (Histone)IBA
04/2015
1Protein Synthesis InhibitorsIBA
09/2012
1CyclinsIBA
09/2012
1silvestrolIBA
09/2012
1Cyclin DIBA
09/2012
1SphingosineIBA
03/2012
1NF-kappa B (NF-kB)IBA
02/2012
1Phosphatidylinositols (Phosphatidylinositol)IBA
02/2012
1Membrane Proteins (Integral Membrane Proteins)IBA
04/2011
1Reactive Oxygen Species (Oxygen Radicals)IBA
04/2011
1Biological ProductsIBA
04/2010
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
09/2009
1alpha- cyano- (3,4- dihydroxy)- N- benzylcinnamideIBA
09/2009
1Proteasome Endopeptidase Complex (Proteasome)IBA
01/2009
1Proteasome InhibitorsIBA
09/2007
1Glucose (Dextrose)FDA LinkGeneric
06/2006
1GemcitabineFDA Link
12/2005
1PlatinumIBA
10/2005
1Hemoglobins (Hemoglobin)IBA
10/2005

Therapy/Procedure

21Therapeutics
07/2022 - 08/2002
11Drug Therapy (Chemotherapy)
12/2018 - 08/2002
3Salvage Therapy
06/2006 - 02/2004
3Radiotherapy
10/2004 - 12/2002
2Stem Cell Transplantation
06/2016 - 11/2008
2Autologous Transplantation
02/2004 - 05/2003